CLEER THE AIR

Discussing the science behind Cleerly's new standard of care for heart disease.

AI-enabled CCTA approach

Cleerly's 2023 Year in Review

4 min read

2023 in Review: A Year of Recognition, Growth, and Continuous Innovation at Cleerly

As we reach the end of 2023 and yet another remarkable year at Cleerly, it’s a great opportunity to reflect on all we’ve accomplished and begin...

Read More »
Cleerly's Quarterly Roundup | Q3 2023

2 min read

Quarterly Roundup: Cleerly's Impressive Run of Events, Speaking Engagements, and Award Wins as 2023 Winds Down

Cleerly has had a busy few months – attending conferences, panel sessions, and winning awards as we all work together to achieve our mission of a...

Read More »

4 min read

Atherosclerosis Treatment Algorithms for Heart Disease Evaluation

Quantification of coronary artery disease (CAD) burden and atherosclerotic plaque type has been shown to be the strongest determinant of future risk...

Read More »

3 min read

How AI-enabled CCTA Creates Value by Reducing Downstream Costs

Care quality is a pillar of the Quadruple Aim for a reason. Stakeholders across the healthcare ecosystem benefit when patients have access to the...

Read More »
Cleerly at the American Heart Association Scientific Sessions 2022

3 min read

Better Defining Heart Disease Risk Through Proper Evaluation

Cleerly’s Medical Affairs team had the opportunity to present at the American Heart Association’s (AHA) 2022 Scientific Sessions this past week in...

Read More »

3 min read

How Cleerly Outperforms Stress Tests

Myocardial perfusion, also known as a "stress test", is today's go-to-method for detecting coronary artery disease - despite limited performance.

Read More »

3 min read

Transforming Cardiac Care: A New Cleerly Webinar Series

There's a little-known fact in cardiology: Most of the care that's provided doesn't prevent heart attacks.

Read More »

1 min read

Cleerly CEO Featured on AWS Health Innovation Podcast

Cleerly CEO James Min, M.D., is a guest on the latest episode of the AWS Health Innovation Podcast hosted by Joe Shonkwiler, M.D.

Read More »
Cleerly's CLARIFY 2 study demonstrates the efficacy of its non-invasive AI-enabled CCTA approach for heart disease evaluation

3 min read

CLARIFY 2 Affirms Cleerly Over Invasive Heart Disease Evaluation Methods

Findings from Cleerly's groundbreaking echo the recent American College of Cardiology guidelines on the use of CCTA for non-invasive heart disease...

Read More »

2 min read

Cleerly Product Release:  Taking Precision Heart Care to the Next Level

As Cleerly makes its way into the clinical workflow of health systems and providers across the US, we are learning valuable information about how to...

Read More »